Back
ProPhase Labs 10K Form
Sell
30
PRPH
ProPhase Labs
Last Price:
$0.35
Seasonality Move:
1.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PRPH News And Ratings
See the #1 stock for the next 7 days that we like better than PRPH
PRPH Financial Statistics
Sales & Book Value
| Annual Sales: | $6.8M |
|---|---|
| Cash Flow: | $-3.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.36 |
| Price / Book: | 0.96 |
Profitability
| EPS (TTM): | -2.16000 |
|---|---|
| Net Income (TTM): | $-43.1M |
| Gross Margin: | $-150K |
| Return on Equity: | -144.22% |
| Return on Assets: | -55.47% |
ProPhase Labs Earnings Forecast
Key ProPhase Labs Financial Ratios
-
The Gross Profit Margin over the past 28 years for PRPH is -2.22%.
-
The Selling, General & Administrative Expenses for PRPH have been equal to 559.60% of Gross Profit Margin.
-
The Research & Development expenses have been 8.77% of Revenue.
-
The Net Earning history of PRPH is -788.24% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 15 years.
ProPhase Labs Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | PRPH |
| CUSIP: | 74345W |
| Website: | prophaselabs.com |
Debt
| Debt-to-Equity Ratio: | 0.28 |
|---|---|
| Current Ratio: | 1.03 |
| Quick Ratio: | 0.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PRPH Technical Analysis vs Fundamental Analysis
Sell
30
ProPhase Labs (PRPH)
is a Sell
Is ProPhase Labs a Buy or a Sell?
-
ProPhase Labs stock is rated a SellThe current ProPhase Labs [PRPH] share price is $0.35. The Score for PRPH is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.